InBios International Inc:企業の製品パイプライン分析

◆英語タイトル:InBios International Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME15191PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InBios International Inc (InBios International) is a medical device company that develops, manufactures and markets medical diagnostic tests for detecting infectious diseases. The company offers products such as assays, ELISA kits, rapid immunoassays, veterinary products, and monoclonal antibodies. Its services comprise research and development and contract manufacturing. The company’s contract manufacturing services comprise reagent preparation, packaging and kit assembly, assay development, computerized label printing, liquid filling, product and process validation, and others. It markets its products across the US. InBios International is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InBios International Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
InBios International Inc Company Overview
InBios International Inc Company Snapshot
InBios International Inc Pipeline Products and Ongoing Clinical Trials Overview
InBios International Inc – Pipeline Analysis Overview
InBios International Inc – Key Facts
InBios International Inc – Major Products and Services
InBios International Inc Pipeline Products by Development Stage
InBios International Inc Pipeline Products Overview
DENV Detect IgA Capture ELISA
DENV Detect IgA Capture ELISA Product Overview
Leprosy Detect ELISA Kit
Leprosy Detect ELISA Kit Product Overview
Malaria Pf/Pv Detect Rapid Test
Malaria Pf/Pv Detect Rapid Test Product Overview
Multiplex Test
Multiplex Test Product Overview
Point-Of-Care Diagnostic Test – Anthrax
Point-Of-Care Diagnostic Test – Anthrax Product Overview
SCoV-2 Ag Detect Rapid Test
SCoV-2 Ag Detect Rapid Test Product Overview
SCoV-2 Detect IgM/IgG Rapid Test
SCoV-2 Detect IgM/IgG Rapid Test Product Overview
Smart Detect SARS-CoV-2 rRT-PCR Kit
Smart Detect SARS-CoV-2 rRT-PCR Kit Product Overview
Strongyloides Detect IgG ELISA
Strongyloides Detect IgG ELISA Product Overview
InBios International Inc – Key Competitors
InBios International Inc – Key Employees
InBios International Inc – Locations And Subsidiaries
Head Office
Recent Developments
InBios International Inc, Recent Developments
Sep 03, 2019: Zika diagnostic test granted market authorization by FDA
May 23, 2019: FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies
Sep 11, 2018: InBios receives FDA Clearance for its DENV Detect NS1 ELISA Test for early detection of Dengue Fever
Sep 26, 2017: HHS advances point-of-care diagnostic test for anthrax
Dec 22, 2016: FDA Warns Health Care Providers Against Relying Solely on Zika Virus Serological IgM Assay Results
Aug 01, 2016: HHS awards $5.1 million to InBios to advance Zika Diagnostic
Apr 08, 2011: Inbios Receives FDA Approval To Market Test To Help Diagnose Dengue Fever
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
InBios International Inc Pipeline Products and Ongoing Clinical Trials Overview
InBios International Inc Pipeline Products by Equipment Type
InBios International Inc Pipeline Products by Indication
InBios International Inc, Key Facts
InBios International Inc, Major Products and Services
InBios International Inc Number of Pipeline Products by Development Stage
InBios International Inc Pipeline Products Summary by Development Stage
DENV Detect IgA Capture ELISA - Product Status
DENV Detect IgA Capture ELISA - Product Description
Leprosy Detect ELISA Kit - Product Status
Leprosy Detect ELISA Kit - Product Description
Malaria Pf/Pv Detect Rapid Test - Product Status
Malaria Pf/Pv Detect Rapid Test - Product Description
Multiplex Test - Product Status
Multiplex Test - Product Description
Point-Of-Care Diagnostic Test - Anthrax - Product Status
Point-Of-Care Diagnostic Test - Anthrax - Product Description
SCoV-2 Ag Detect Rapid Test - Product Status
SCoV-2 Ag Detect Rapid Test - Product Description
SCoV-2 Detect IgM/IgG Rapid Test - Product Status
SCoV-2 Detect IgM/IgG Rapid Test - Product Description
Smart Detect SARS-CoV-2 rRT-PCR Kit - Product Status
Smart Detect SARS-CoV-2 rRT-PCR Kit - Product Description
Strongyloides Detect IgG ELISA - Product Status
Strongyloides Detect IgG ELISA - Product Description
InBios International Inc, Key Employees
Glossary

★海外企業調査レポート[InBios International Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cascadian Therapeutics Inc (CASC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Allegis Group, Inc.:企業の戦略的SWOT分析
    Allegis Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • The Nassau Companies of New York:企業の戦略的SWOT分析
    The Nassau Companies of New York - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Xi’An Catering Co., Ltd.:企業の戦略・SWOT・財務分析
    Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GREE, Inc. (3632):企業の財務・戦略的SWOT分析
    GREE, Inc. (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Advantest Corporation:企業の戦略・SWOT・財務情報
    Advantest Corporation - Strategy, SWOT and Corporate Finance Report Summary Advantest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • YTL Power International Berhad:発電所・企業SWOT分析
    YTL Power International Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Bank Of The Philippine Islands:企業の戦略・SWOT・財務分析
    Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank Of The Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Banque Cantonale de Geneve Private Banking:企業の戦略・SWOT・財務情報
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Banner Health-製薬・医療分野:企業M&A・提携分析
    Summary Banner Health (Banner) is a nonprofit health care system that offers hospital care, hospice care, nursing registries, surgery center, laboratories and rehabilitation services. It also provides community-based social service programs and health-related educational programs. The organization o …
  • Abano Healthcare Group Ltd (ABA):企業の財務・戦略的SWOT分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd, is a healthcare service provider that offers dental, audiology, radiology and medical services. The company also operates business in community pathology and radiology sector; and healthcare markets such as ab …
  • Bridgford Foods Corporation:企業の戦略・SWOT・財務分析
    Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Carlisle Companies Incorporated:企業のM&A・事業提携・投資動向
    Carlisle Companies Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carlisle Companies Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Saline Water Conversion Corp:発電所・企業SWOT分析
    Saline Water Conversion Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Archer Daniels Midland Co:戦略・SWOT・企業財務分析
    Archer Daniels Midland Co - Strategy, SWOT and Corporate Finance Report Summary Archer Daniels Midland Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • JSC Gazprom Neft:企業の戦略・SWOT・財務情報
    JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report Summary JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gene Techno Science Co Ltd (4584):企業の財務・戦略的SWOT分析
    Summary Gene Techno Science Co Ltd (GTS) develops and markets drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological, biosimilar and regenerative medicine in the therapy areas of renal disease, immunological, oncology, ophthalmic, and bone related di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆